TWD 84.6
(-4.94%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 15.9 Million TWD | -53.74% |
2022 | 34.37 Million TWD | 532.82% |
2021 | 5.43 Million TWD | -78.04% |
2020 | 24.73 Million TWD | 2.58% |
2019 | 24.11 Million TWD | 23.34% |
2018 | 19.55 Million TWD | 21.04% |
2017 | 16.15 Million TWD | 58.61% |
2016 | 10.18 Million TWD | 693.22% |
2015 | 1.28 Million TWD | -87.66% |
2014 | 10.4 Million TWD | 54.94% |
2013 | 6.71 Million TWD | 0.0% |
2012 | - TWD | 0.0% |
2011 | - TWD | 0.0% |
2010 | - TWD | 0.0% |
2009 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 22.03 Million TWD | -34.93% |
2024 Q1 | 33.86 Million TWD | 112.96% |
2023 Q1 | 20.63 Million TWD | -39.98% |
2023 Q3 | 27.08 Million TWD | -30.28% |
2023 Q4 | 15.9 Million TWD | -41.28% |
2023 FY | 15.9 Million TWD | -53.74% |
2023 Q2 | 38.83 Million TWD | 88.25% |
2022 Q1 | 33.93 Million TWD | 524.67% |
2022 Q3 | 47.03 Million TWD | -22.49% |
2022 Q4 | 34.37 Million TWD | -26.91% |
2022 FY | 34.37 Million TWD | 532.82% |
2022 Q2 | 60.67 Million TWD | 78.82% |
2021 Q2 | 11.59 Million TWD | -21.97% |
2021 Q3 | 8.83 Million TWD | -23.83% |
2021 Q4 | 5.43 Million TWD | -38.48% |
2021 Q1 | 14.85 Million TWD | -39.95% |
2021 FY | 5.43 Million TWD | -78.04% |
2020 Q4 | 24.73 Million TWD | 76.46% |
2020 Q3 | 14.02 Million TWD | -41.08% |
2020 FY | 24.73 Million TWD | 2.58% |
2020 Q1 | 14.42 Million TWD | -40.21% |
2020 Q2 | 23.79 Million TWD | 65.02% |
2019 Q3 | 32.19 Million TWD | 56.19% |
2019 Q4 | 24.11 Million TWD | -25.1% |
2019 FY | 24.11 Million TWD | 23.34% |
2019 Q1 | 10.1 Million TWD | -48.3% |
2019 Q2 | 20.61 Million TWD | 103.92% |
2018 Q1 | 11.46 Million TWD | -29.02% |
2018 Q4 | 19.55 Million TWD | 196.02% |
2018 Q3 | 6.6 Million TWD | -38.64% |
2018 Q2 | 10.76 Million TWD | -6.12% |
2018 FY | 19.55 Million TWD | 21.04% |
2017 Q1 | 9.66 Million TWD | -5.11% |
2017 Q4 | 16.15 Million TWD | -8.83% |
2017 Q3 | 17.71 Million TWD | 106.32% |
2017 Q2 | 8.58 Million TWD | -11.14% |
2017 FY | 16.15 Million TWD | 58.61% |
2016 Q3 | 10.52 Million TWD | -2.24% |
2016 FY | 10.18 Million TWD | 693.22% |
2016 Q2 | 10.76 Million TWD | 1076299900.0% |
2016 Q1 | 1.00 TWD | -100.0% |
2016 Q4 | 10.18 Million TWD | -3.2% |
2015 Q3 | 1.00 TWD | -100.0% |
2015 Q4 | 6.84 Million TWD | 684899900.0% |
2015 Q2 | 5.01 Million TWD | -34.25% |
2015 Q1 | 7.63 Million TWD | -26.68% |
2015 FY | 1.28 Million TWD | -87.66% |
2014 Q3 | 1.00 TWD | -100.0% |
2014 Q2 | 5.91 Million TWD | 38.34% |
2014 Q1 | 4.27 Million TWD | -36.33% |
2014 FY | 10.4 Million TWD | 54.94% |
2014 Q4 | 10.4 Million TWD | 1040699900.0% |
2013 Q2 | 3.16 Million TWD | 316599900.0% |
2013 Q4 | 6.71 Million TWD | 72.32% |
2013 Q3 | 3.89 Million TWD | 23.12% |
2013 Q1 | 1.00 TWD | 0.0% |
2013 FY | 6.71 Million TWD | 0.0% |
2012 FY | - TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2012 Q3 | - TWD | 0.0% |
2012 Q1 | - TWD | 0.0% |
2012 Q4 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2011 FY | - TWD | 0.0% |
2010 FY | - TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | 96.543% |
Level Biotechnology Inc. | 88.85 Million TWD | 82.104% |
Sagittarius Life Science Corp | 31.54 Million TWD | 49.586% |
NeoCore Technology Co., Ltd. | 66.38 Million TWD | 76.046% |
TaiMed Biologics Inc. | 1.26 Billion TWD | 98.743% |
GlycoNex Incorporation | 17.4 Million TWD | 8.631% |
VBI | 10.03 Million TWD | -58.455% |
GeneReach Biotechnology Corp. | 67.37 Million TWD | 76.399% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | 24.893% |
Visgeneer Inc. | 49.07 Million TWD | 67.597% |
Mycenax Biotech Inc. | 112.32 Million TWD | 85.844% |
Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | 83.024% |
G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | 30.575% |
Medigen Vaccine Biologics Corporation | 383.63 Million TWD | 95.855% |
TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 432.032% |
Enimmune corporation | 15.7 Million TWD | -1.274% |
TaiRx, Inc. | 11 Thousand TWD | -144454.545% |
CHO Pharma, Inc. | 1.00 TWD | -1590099900.0% |
EirGenix Inc. | 680.63 Million TWD | 97.664% |
BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | 51.11% |
Sunny Pharmtech Inc. | 97.03 Million TWD | 83.614% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | 3.892% |
Feng Chi Biotech Corp. | 19.03 Million TWD | 16.473% |
Bio Preventive Medicine Corp. | 1.23 Million TWD | -1184.41% |
Lukas Biomedical Inc. | 36.72 Million TWD | 56.703% |
RBC Bioscience Corporation | 44.42 Million TWD | 64.205% |
BiOptic Inc. | 161.07 Million TWD | 90.128% |
BRIM Biotechnology, Inc. | -6.23 Million TWD | 354.905% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -158.091% |
Syngen Biotech Co.,Ltd. | 348.98 Million TWD | 95.444% |
Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -3048.713% |
SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -409.158% |
Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | 74.148% |
Neith Corporation | 463 Thousand TWD | -3334.341% |
Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 17383.884% |
NaviFUS Corp. | 6.87 Million TWD | -131.355% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -30.679% |
Sinew Pharma Inc. | -766 Thousand TWD | 2175.849% |
Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -1361.489% |
Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | 90.253% |
Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | 84.698% |
AP Biosciences Inc | - TWD | -Infinity% |
Medigen Biotechnology Corp. | 546.9 Million TWD | 97.093% |
3D Global Biotech Inc. | 3.59 Million TWD | -342.309% |
Pharmosa Biopharm Inc. | 21.9 Million TWD | 27.423% |
Intech Biopharm Corporation | 41.52 Million TWD | 61.707% |
Oneness Biotech Co., Ltd. | 122.73 Million TWD | 87.045% |
Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 296.26% |
TWi Biotechnology, Inc. | -435 Thousand TWD | 3755.402% |
Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | 76.984% |
TCI GENE Inc. | 54.84 Million TWD | 71.008% |
MegaPro Biomedical Co., Ltd | 20.51 Million TWD | 22.472% |
Senhwa Biosciences, Inc. | - TWD | -Infinity% |
Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | 61.183% |
NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | 80.726% |
Savior Lifetec Corporation | 860.04 Million TWD | 98.151% |
TaiGen Biopharmaceuticals Holdings Limited | 34.15 Million TWD | 53.443% |
OBI Pharma, Inc. | 25.93 Million TWD | 38.682% |
Meribank Biotech Co., Ltd | 6.9 Million TWD | -130.216% |
Acepodia, Inc. | 39.52 Million TWD | 59.773% |
Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -1454.35% |